Table 2.

Type of the First Thrombotic Event and Age at the Time of Development for the 116 Symptomatic Relatives

Total Coagulation Defect
No Defect Antithrombin Deficiency Protein C Deficiency Protein S Deficiency Factor V LeidenDouble Defects
Symptomatic relatives/total relatives (%) 116/723 (16%)  15/327 (5%)  30/85 (35%) 19/64 (30%)  15/41 (37%)  35/200 (18%)  2/6 (33%) 
Symptomatic men/women  45/71  5/10  16/14  5/14 10/5  7/28  2/0  
Relatives with venous thrombosis/total relatives (%)  99/723 (14%)  9/327 (3%)  30/85 (35%) 16/64 (25%)  12/41 (29%)  30/200 (15%)  2/6 (33%) 
 Venous thromboembolism  74/99 (75%)  3/9 (33%) 27/30 (90%)  14/16 (88%)  12/12 (100%) 17/30 (57%)  1/2 (50%)  
 Superficial vein thrombosis 25/99 (25%)  6/9 (67%)  3/30 (10%)  2/16 (13%) 0/12  13/30 (43%)  1/2 (50%)  
Relatives with arterial thrombosis/total relatives (%)  17/723 (2%)  6/327 (2%) 0/85  3/64 (5%)  3/41 (7%)  5/200 (3%)  0/6 
Age at thrombosis (yr), mean ± SD Range  34 ± 14 10-80  40 ± 14* 21-62 35 ± 15 10-77  40 ± 9* 20-58  40 ± 15 20-67  37 ± 15 15-80  17 ± 2 15-19 
Total Coagulation Defect
No Defect Antithrombin Deficiency Protein C Deficiency Protein S Deficiency Factor V LeidenDouble Defects
Symptomatic relatives/total relatives (%) 116/723 (16%)  15/327 (5%)  30/85 (35%) 19/64 (30%)  15/41 (37%)  35/200 (18%)  2/6 (33%) 
Symptomatic men/women  45/71  5/10  16/14  5/14 10/5  7/28  2/0  
Relatives with venous thrombosis/total relatives (%)  99/723 (14%)  9/327 (3%)  30/85 (35%) 16/64 (25%)  12/41 (29%)  30/200 (15%)  2/6 (33%) 
 Venous thromboembolism  74/99 (75%)  3/9 (33%) 27/30 (90%)  14/16 (88%)  12/12 (100%) 17/30 (57%)  1/2 (50%)  
 Superficial vein thrombosis 25/99 (25%)  6/9 (67%)  3/30 (10%)  2/16 (13%) 0/12  13/30 (43%)  1/2 (50%)  
Relatives with arterial thrombosis/total relatives (%)  17/723 (2%)  6/327 (2%) 0/85  3/64 (5%)  3/41 (7%)  5/200 (3%)  0/6 
Age at thrombosis (yr), mean ± SD Range  34 ± 14 10-80  40 ± 14* 21-62 35 ± 15 10-77  40 ± 9* 20-58  40 ± 15 20-67  37 ± 15 15-80  17 ± 2 15-19 

*P = .04 compared with double defects.

or Create an Account

Close Modal
Close Modal